Related Experiment Video
Updated: Feb 2, 2026
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
Published on: April 14, 2023
Update on prevention and treatment of sudden cardiac arrest
Yuliya Krokhaleva1, Marmar Vaseghi1
1UCLA Cardiac Arrhythmia Center, UCLA Health System, David Geffen School of Medicine at UCLA, 100 UCLA Medical Plaza, Suite 660, Los Angeles, CA, USA.
Insights
Sudden cardiac arrest (SCA) is a major cause of death. Treatments include internal cardioverter-defibrillators, acute care strategies, and novel neuromodulation for ventricular arrhythmias.
Area of Science:
- Cardiology
- Public Health
- Medical Technology
Background:
- Sudden cardiac arrest (SCA) is the primary cause of cardiovascular mortality.
- Causes of SCA vary by age, with inherited conditions prevalent in younger individuals and coronary artery disease in those over 35.
- Internal cardioverter-defibrillators (ICDs) are crucial for SCA prevention.
Purpose of the Study:
- To review current management strategies for sudden cardiac arrest.
- To highlight the role of ICDs in prevention and treatment.
- To explore emerging therapies like neuromodulation for ventricular arrhythmias.
Main Methods:
- Literature review of sudden cardiac arrest epidemiology, prevention, and treatment.
- Analysis of acute and chronic management protocols.
- Discussion of novel therapeutic modalities.
Main Results:
- Age-specific etiologies of SCA identified.
- ICDs established as a cornerstone of prevention.
- Acute interventions (chain of survival, reperfusion, hypothermia) improve outcomes.
- Ventricular tachycardia ablation enhances quality of life and may improve survival.
- Neuromodulation shows promise for ventricular arrhythmia treatment.
Conclusions:
- Sudden cardiac arrest management requires a multi-faceted approach.
- Established and novel therapies are critical for reducing mortality and improving patient outcomes.
- Further research into neuromodulation is warranted for ventricular arrhythmias.
Abstract:
Sudden cardiac arrest is the leading cause of cardiovascular mortality, posing a substantial public health burden. The incidence and epidemiology of sudden death are a function of age, with primary arrhythmia syndromes and inherited cardiomyopathies representing the predominant causes in younger patients, while coronary artery disease being the leading etiology in those who are 35 years of age and older. Internal cardioverter defibrillators remain the mainstay of primary and secondary prevention of sudden cardiac arrest. In the acute phase, cardiac chain of survival, early reperfusion, and therapeutic hypothermia are the key steps in improving outcomes. In the chronic settings, ventricular tachycardia ablation has been shown to improve patients' quality of life by reducing frequency of defibrillator shocks. Moreover, recent studies have suggested that it may increase survival. Neuromodulation represents a novel therapeutic modality that has a great potential for improving treatment of ventricular arrhythmias.
Related Concept Videos
02:59Cancer Prevention
Some...
01:14Prevention of Further Absorption of Poison
01:30Preventive Healthcare Services
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:22Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...